Angus C. Russell, Director at TherapeuticsMD, Inc. (TXMD), bought 10,000 shares at $2.77 ($28K) on 2019-08-23, disclosed to the SEC on 2019-08-26.
Open-market purchase of $28k TXMD by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| MNKKQ | SELL | 2020-11-16 | $7K | — | Filing → |
| TXMD | BUY | 2019-08-15 | $99K | — | Filing → |
| BTX | BUY | 2015-11-10 | $192K | — | Filing → |